Healthcare

FDA approves first test for opioid addiction risk

By Gabrielle M. Etzel
Published December 20, 2023 3:55pm ET
Add Washington Examiner on Google
FDA approves first test for opioid addiction risk
President Trump signed into law the FDA Reauthorization Act of 2017 on Friday. It reauthorizes a program in which drug and device makers pay the FDA a fee for every new product application, and the agency uses that money to hire more people and speed up approvals. (AP Photo/Andrew Harnik, File) | Andrew Harnik


The Food and Drug Administration on Tuesday approved the first-ever genetic test to assess if a patient is at risk of opioid use addiction.

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.

Tag:

FDA genetic testing Genetics Opioids Pharmaceutical Industry